173 related articles for article (PubMed ID: 15917307)
1. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists.
Ebert B; Seidel A; Lampen A
Carcinogenesis; 2005 Oct; 26(10):1754-63. PubMed ID: 15917307
[TBL] [Abstract][Full Text] [Related]
2. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate.
Ebert B; Seidel A; Lampen A
Toxicol Sci; 2007 Apr; 96(2):227-36. PubMed ID: 17077187
[TBL] [Abstract][Full Text] [Related]
3. Polycyclic aromatic hydrocarbons in food--efflux of the conjugated biomarker 1-hydroxypyrene is mediated by Breast Cancer Resistance Protein (ABCG2) in human intestinal Caco-2 cells.
Hessel S; Lampen A; Seidel A
Food Chem Toxicol; 2013 Dec; 62():797-804. PubMed ID: 24140465
[TBL] [Abstract][Full Text] [Related]
4. Induction of phase-1 metabolizing enzymes by oltipraz, flavone and indole-3-carbinol enhance the formation and transport of benzo[a]pyrene sulfate conjugates in intestinal Caco-2 cells.
Ebert B; Seidel A; Lampen A
Toxicol Lett; 2005 Aug; 158(2):140-51. PubMed ID: 15890477
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid enhances the transport of phase II metabolites of benzo[a]pyrene by inducing the Breast Cancer Resistance Protein expression in Caco-2 cells.
Hessel S; Lampen A
Toxicol Lett; 2010 Aug; 197(2):151-5. PubMed ID: 20562004
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides.
Sergent T; Dupont I; Jassogne C; Ribonnet L; van der Heiden E; Scippo ML; Muller M; McAlister D; Pussemier L; Larondelle Y; Schneider YJ
Toxicol Lett; 2009 Feb; 184(3):159-68. PubMed ID: 19070657
[TBL] [Abstract][Full Text] [Related]
7. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
Graber-Maier A; Gutmann H; Drewe J
Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers.
Wright JA; Haslam IS; Coleman T; Simmons NL
Eur J Pharmacol; 2011 Dec; 672(1-3):70-6. PubMed ID: 22004608
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
Tan KP; Wang B; Yang M; Boutros PC; Macaulay J; Xu H; Chuang AI; Kosuge K; Yamamoto M; Takahashi S; Wu AM; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2010 Aug; 78(2):175-85. PubMed ID: 20460431
[TBL] [Abstract][Full Text] [Related]
11. Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells.
Bothe H; Götz C; Stobbe-Maicherski N; Fritsche E; Abel J; Haarmann-Stemmann T
Arch Biochem Biophys; 2010 Jun; 498(2):111-8. PubMed ID: 20403331
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid inhibits the uptake of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by inducing the efflux transporters expression in Caco-2 cells.
Hong YJ; Yang SY; Nam MH; Koo YC; Lee KW
Biol Pharm Bull; 2015; 38(2):201-7. PubMed ID: 25399682
[TBL] [Abstract][Full Text] [Related]
14. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
[TBL] [Abstract][Full Text] [Related]
15. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
16. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine.
Pavek P; Merino G; Wagenaar E; Bolscher E; Novotna M; Jonker JW; Schinkel AH
J Pharmacol Exp Ther; 2005 Jan; 312(1):144-52. PubMed ID: 15365089
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
[TBL] [Abstract][Full Text] [Related]
19. Oleic acid decreases BCRP mediated efflux of mitoxantrone in Caco-2 cell monolayers.
Aspenström-Fagerlund B; Tallkvist J; Ilbäck NG; Glynn AW
Food Chem Toxicol; 2012 Oct; 50(10):3635-45. PubMed ID: 22819932
[TBL] [Abstract][Full Text] [Related]
20. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
